HRMY
HRMY
NASDAQ · Pharmaceuticals

Harmony Biosciences Holdings

Small-Cap Stocks Pharmaceutical Stocks Healthcare Stocks
$27.72
-0.09 (-0.32%)
As of Mar 22, 10:03 PM ET ·
Analyst Consensus
Buy
17
Analysts
High
Coverage
Buy 11 65%
Hold 5 29%
Sell 1 6%
Price Target
Analyst Price Target +237.4% upside
Low Target $67.60
Average Target $93.52
High Target $113.52
Current Price $27.72
Current
$27.72
Target
$93.52
$67.60 $93.52 avg $113.52
Scenario Analysis
Bear Case
$67.60
143.9%
Low target
Base Case
$93.52
+237.4%
Avg target
Bull Case
$113.52
+309.5%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$40.87
-32.2% from high
52-Week Low
$25.52
+8.6% from low
50-Day SMA
$37.42
-25.9% vs SMA
200-Day SMA
$34.21
-19.0% vs SMA
RSI (14)
38.4
Neutral
Target vs 52W High
$93.52
+128.8% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
 Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
 Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
 Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
 Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
 Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
 Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
 Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
 Buy 18 67% $122.82 +809.8%